Skip to content

Determinants and Outcomes of High vs. Low Ultra-processed Feeding

Determinants and Outcomes of High vs. Low Ultra-processed Feeding

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06310603
Enrollment
60
Registered
2024-03-15
Start date
2023-08-09
Completion date
2025-08-09
Last updated
2025-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Nutrition

Brief summary

The goal of this clinical trial is to learn about, test, and compare health outcomes of high vs. low-processed feeding. The main question\[s\] it aims to answer are: • Does consuming a diet rich in unprocessed food improve various health outcomes? Participants will either be instructed to consume a diet rich in unprocessed food for 6 months, or consume their typical diet for 6 months. At various points in the study there will be metabolic health data collected. If there is a comparison group: Researchers will compare the low-processed group to the typical diet group to see if there are improvements in metabolic health.

Interventions

OTHERLow-Processed Food Diet

Participants that receive intervention will be instructed to eat a diet rich in unprocessed/minimally-processed foods, as described by the NOVA food classification system

Sponsors

Oklahoma State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* rural county resident * not meeting physical activity guidelines for adults * consuming a typical Western diet (rich in UPF)

Exclusion criteria

* chronic diseases * tobacco, vape, or illicit drug use * overly active * already on a restrictive diet (e.g., keto, intermittent fasting)

Design outcomes

Primary

MeasureTime frameDescription
Body Composition1 yearUsing Dual-energy X-ray absorptiometry(DXA), body composition will be assessed
Fat-Free Mass Percentage1 yearUsing Dual-energy X-ray absorptiometry(DXA), fat-free mass will be assessed
Fat Mass Percentage1 yearUsing Dual-energy X-ray absorptiometry(DXA), fat mass percentage will be assessed
Body Weight1 yearUsing a standard scale, body weight in kg will be assessed

Secondary

MeasureTime frameDescription
HDL1 yearBlood draw followed by a Piccolo scan will analyze HDL in the blood
Alanine transaminase (ALT)1 yearBlood draw followed by a Piccolo scan will analyze ALT in the blood
Aspartate transaminase (AST)1 yearBlood draw followed by a Piccolo scan will analyze AST in the blood
LDL1 yearPiccolo scan will analyze LDL in the blood
Glucose Levels1 yearBlood draw followed by a Piccolo scan will analyze glucose in the blood
Cholesterol Levels1 yearBlood draw followed by a Piccolo scan will analyze glucose in the blood
Triglyceride Levels1 yearBlood draw followed by a Piccolo scan will analyze Triglyceride levels in the blood

Other

MeasureTime frameDescription
Energy Intake1 year3-Day Food Logs will record caloric intake at various points
Gut Microbiome Collection1 yearStool kits administered for fecal collection will be used for gut microbiome collection
Energy Expenditure1 yearResting Metabolic Rate will be used to find resting energy expenditure and an accelerometer will measure expended energy through fitness, combined these will show energy expenditure

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026